Inactive Instrument

Company Skinvisible Inc OTC Bulletin Board

Equities

US8307031042

Personal Products

Business Summary

Skinvisible, Inc., through its wholly owned subsidiary Skinvisible Pharmaceuticals Inc., is a pharmaceutical research and development (R&D) company. The Company is engaged in developing and patenting a polymer delivery system, Invisicare, and formulating over forty topical skin products. Its flagship product, Pivotal, is a patented polymer delivery system technology, Invisicare. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active. Invisicare is specifically formulated to carry water-insoluble active and certain cationic active ingredients in water-based products without the use of alcohol, silicones, waxes, or other organic solvents. It is also exploring opportunities in medical markets outside the dermatology market.

Sales per Business

USD in Million2022Weight2023Weight Delta
Topical, Transdermal, and Mucosal Polymer-based Delivery System Technologies and Formulations
100.0 %
0 100.0 % 0 100.0 % -92.84%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
0 100.0 % 0 100.0 % -92.84%

Managers

Managers TitleAgeSince
Chief Executive Officer 75 98-03-04
Public Communications Contact 61 -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 75 98-03-04
Director/Board Member 51 17-09-21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,539,843 4,385,377 ( 96.60 %) 0 96.60 %

Shareholders

NameEquities%Valuation
154,466 3.402 % 10 658 $
36,000 0.7930 % 2 484 $
0 0.000000 % - $

Company contact information

Skinvisible, Inc.

6320 South Sandhill Road Suite 10

89120, Las Vegas

+

http://www.skinvisible.com
address Skinvisible Inc